© 2025 Connecticut Public

FCC Public Inspection Files:
WEDH · WEDN · WEDW · WEDY
WEDW-FM · WNPR · WPKT · WRLI-FM
Public Files Contact · ATSC 3.0 FAQ
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Alexion Opens New Haven Global Headquarters

Lori Mack
/
WNPR
Patients and their families join politicians and executives at the opening of Alexion's global headquarters.
Alexion focuses on treatments for rare diseases.

Alexion Pharmaceuticals said it will have 1,000 workers at its new headquarters building in New Haven by the end of this month. Connecticut’s most successful homegrown bioscience company, Alexion showed off its global headquarters Monday. 

The $100 million facility is one of the cornerstones of the city’s Downtown Crossing Development. Alexion is returning to its roots with the move.

It began as a startup founded by a professor from Yale, but as it expanded and became more successful, the company moved to Cheshire. Now, lured by state incentives, as well as a growing bioscience concentration around Yale-New Haven Hospital, it will take up its new headquarters at 100 College Street.

CEO David Hallal said they expect to bring more drugs to market from their new base.

"Our employees are already enjoying the rich experiences that the city has to offer," he told a crowd assembled for the opening ceremony. "We are pleased to be stimulating the New Haven-based biotech industry, and look forward to being an active part of the community."

Alexion focuses on treatments for rare diseases. The drug that began its success is Soliris, now approved to treat two different conditions.

Founder Dr. Leonard Bell said returning to New Haven is a natural step.

"I'm very pleased that the tiny Alexion of 1992 is now the thriving 3,000 employee, multi-national biopharmaceutical firm helping patients in over 50 countries around the world," he said. "The Alexion of 2016 is in the position to come back to New Haven and help our city grow to its next level."

Monday’s official opening happened on Rare Disease Day. Alexion had on hand several patients and their families who have been helped by the company’s medications.

Harriet Jones is Managing Editor for Connecticut Public Radio, overseeing the coverage of daily stories from our busy newsroom.

The independent journalism and non-commercial programming you rely on every day is in danger.

If you’re reading this, you believe in trusted journalism and in learning without paywalls. You value access to educational content kids love and enriching cultural programming.

Now all of that is at risk.

Federal funding for public media is under threat and if it goes, the impact to our communities will be devastating.

Together, we can defend it. It’s time to protect what matters.

Your voice has protected public media before. Now, it’s needed again. Learn how you can protect the news and programming you depend on.

SOMOS CONNECTICUT is an initiative from Connecticut Public, the state’s local NPR and PBS station, to elevate Latino stories and expand programming that uplifts and informs our Latino communities. Visit CTPublic.org/latino for more stories and resources. For updates, sign up for the SOMOS CONNECTICUT newsletter at ctpublic.org/newsletters.

SOMOS CONNECTICUT es una iniciativa de Connecticut Public, la emisora local de NPR y PBS del estado, que busca elevar nuestras historias latinas y expandir programación que alza y informa nuestras comunidades latinas locales. Visita CTPublic.org/latino para más reportajes y recursos. Para noticias, suscríbase a nuestro boletín informativo en ctpublic.org/newsletters.

The independent journalism and non-commercial programming you rely on every day is in danger.

If you’re reading this, you believe in trusted journalism and in learning without paywalls. You value access to educational content kids love and enriching cultural programming.

Now all of that is at risk.

Federal funding for public media is under threat and if it goes, the impact to our communities will be devastating.

Together, we can defend it. It’s time to protect what matters.

Your voice has protected public media before. Now, it’s needed again. Learn how you can protect the news and programming you depend on.

Connecticut Public’s journalism is made possible, in part by funding from Jeffrey Hoffman and Robert Jaeger.